-
-
-
-
-
-
-
Trinity Biotech advances CGM+ device toward pivotal trial in 2026
-
-
-
-
-
-
-
Trinity Biotech secures funding agreements with Perceptive Advisors
-
-
-
-
-
-
-
Trinity Biotech launches FDA-cleared preeclampsia test service
-
-
-
-
-
-
-
Trinity Biotech (TRIB) Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV
-
-
-
-
-
-
-
Trinity Biotech (TRIB) Appoints Adrian Donohue as Chief Commercial Officer
-
-
-
-
-
428,850 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

